Sexual dysfunction in HIV-positive men is multi-factorial: A study of prevalence and associated factors

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 19, Issue 8, 2007, Pages 955-965

  Asboe, D ^a   Catalan, J ^b   Mandalia, S ^a   Dedes, N ^c   Florence, E ^d   Schrooten, W ^d   Noestlinger, C ^d   Colebunders, R ^d  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b South Kensington and Chelsea Mental Health Centre   (United Kingdom)

^c Synthesis   (Greece)

^d INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIRETROVIRUS AGENT; METHADONE; PSYCHOTROPIC AGENT; SILDENAFIL; TESTOSTERONE;

ADULT; AFRICA SOUTH OF THE SAHARA; ANAMNESIS; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; ERECTILE DYSFUNCTION; ETHNICITY; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIVARIATE ANALYSIS; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SELF EVALUATION; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; TREATMENT DURATION;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CROSS-SECTIONAL STUDIES; ERECTILE DYSFUNCTION; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; QUESTIONNAIRES; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL;

EID: 34548648071     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540120701209847     Document Type: Article

References (18)

1. Araujo, A.B., Durante, R., Feldman, H.A., Goldstein, I., & McKinlay, J.B. (1998). The relationship between depressive symptoms and male erectile dysfunction: Cross-sectional results from the Massachusetts Male Aging Study. Psychological Medicine, 60, 458-465.
2. Bruckert, E., Giral, P., Heshmati, H.M., & Turpin, G. (1996). Men treated with hypolipidaemic drugs complain more frequently of erectile dysfunction. Journal Clinical Pharmacological Therapy, 21, 89-94.
3. Catalan, J., Klimes, I., Day, A., Garrod, A., Bond, A., & Gallwey, J. (1992a). The psychosocial impact of HIV infection in gay men: A controlled investigation and factors associated with psychiatric morbidity. British Journal Psychiatry, 161, 774-778.
4. Catalan, J., Klimes, I., Bond, A., Day, A., Garrod, A., & Rizza, C. (1992b). The psychosocial impact of HIV infection in men with haemophilia: Controlled investigation and factors associated with psychiatric morbidity. Journal of Psychosomatic Research, 36, 409-416.
5. Collazos, J., Mayo, J., Martinez, E., et al. (2002). Sexual dysfunction in HIV-infected patients treated with highly active antiretroviral therapy. Journal of AIDS, 31, 322-326.
6. Colson, E., Keller, M., Saz, P., et al. (2002). Male sexual dysfunction associated with antiretroviral therapy. Journal of AIDS, 30, 27-32.
7. Derby, C.A., Barbour, M.M., Hume, A.L., & McKinlay, J.B. (2001). Drug therapy and prevalence of erectile dysfunction in the Massachusetts Male Aging Study cohort. Pharmacotherapy, 21, 676-683.
8. Esposito, K., & Giugliano, D. (2005). Obesity, the metabolic syndrome and sexual dysfunction. International Journal Impotence Research, 17, 391-398.
9. Fonseca, V., & Jawa, A. (2005). Endothelial and erectile dysfunction, diabetes mellitus and the metabolic syndrome: Common pathways and treatments. American Journal of Cardiology, 96, M13-M18.
10. Lallemand, F., Salhi, Y., Linard, F., et al. (2002). Sexual dysfunction in 156 ambulatory HIV-infected men receiving high active antiretroviral therapy combinations with and without protease inhibitors. Journal of AIDS, 30, 187-190.
11. Madersbacher, S., Temml, C., Racz, U., et al. (2003). Prevalence and risk factors for erectile dysfunction in Austria-analysis of a health screening project. Wien Klin Wochenschr, 115, 822-830.
12. Martinez, E., Collazos, J., Mayo, J., et al. (1999). Sexual dysfunction with protease inhibitors. Lancet, 353, 810.
13. Rizvi, K., Hampson, J.P., & Harvey, J.N. (2002). Do lipid-lowering drugs cause erectile dysfunction? A systematic review. Family Practice, 19, 95-98.
14. Rosen, R.C., Riley, A., Wagner, G., Osterloh, I.H., Kirkpatrick, J., & Mishra, A. (1997). The international index of erectile function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology, 49, 822-830.
15. Schrooten, W., Colebunders, R., Youle, M., et al. (2001). Sexual dysfunction associated with protease inhibitors containing highly active antiretroviral treatment. AIDS, 15, 1019-1023.
16. Sollima, S., Maurizio, O., Muscia, F., et al. (2001). Protease inhibitors and erectile dysfunction. AIDS, 15, 2331-2333.
17. Tan, J.K., Hong, C.Y., Png, D.J., Liew, L.C., & Wong, M.L. (2003). Erectile dysfunction in Singapore: Prevalence and its associated factors - a population based study. Singapore Medical Journal, 44, 20-26.
18. Trotta, M.P., Ammassari, A., Cozzi-Lepri, A., et al. (2003). Adherence to highly active antiretroviral therapy is better in patients receiving non-nucleoside reverse transcriptase inhibitor-containing regimens than in those receiving protease inhibitor-containing regimens. AIDS, 17, 1099-1102.